Zai Lab aims to raise $200M; Kronos Bio to seek ‘strategic’ options

Plus, news about Allogene, Telix, Cullgen, Pulmatrix, Gilead, Innocoll, Durect and Sensei:

Zai Lab’s $200M offering: The Shanghai-based drugmaker is

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Make the Diagnosis: A Man With a Very Painful Knee and a Complex Medical History

Presentation A 65-year-old man presented to the doctor with complaints of severe knee pain, decreased range of motion, and a painful skin lesion that developed

August 10, 2023

Natural killer cells lead the charge in cancer treatment innovation

Review synthesizes research on NK cells’ role in cancer immunity and their potential in therapeutics through bioengineering, immune checkpoint inhibitors, and cell engagers, highlighting ongoing

February 23, 2024

Is Guillain-Barré syndrome induced by SARS-CoV-2 vaccination?

Researchers investigated whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines induced Guillain-Barré syndrome.

June 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.